Progen Pharmaceuticals Limited

ASX:PGL ISIN:AU000000PGL5

May 26, 2012

OVERVIEW | NEWS | MULTIMEDIA | RESEARCH

Progen Pharmaceuticals Limited Company Summary

Progen Pharmaceuticals Limited (Progen) is an Australia-based company. During the fiscal year ended June 30, 2008 (fiscal 2008), the principal activities of the Company were discovery, research and development of biopharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biological products. The product platforms include Epigenetics, Angiogenesis and Cell Proliferation. On July 2, 2008, the Company spun-out its manufacturing business as a wholly owned subsidiary company, PharmaSynth Pty Ltd (PharmaSynth). PharmaSynth is focused on the provision of contract pharmaceutical manufacturing services. On July 23, 2008, the Company discontinued the PI-88 phase III study in liver cancer (the PATHWAY trial). In February 2008, the Company completed the acquisition of the United States-based biotechnology company CellGate, Inc.

COMPANY DATA

	Headquarters	16 Benson Street, Toowong, QLD 4066, Australia

	Telephone	+61-7-38423333

	Principal Sector	Health & Pharm

	Principal Industry	Pharmaceutical

	Homepage	www.progen.com.au

Key Developments: Progen Pharmaceuticals Limited

	Benitec Limited (ASX:BLT) Announce A Board and Senior Management Update MAR 29, 2010 10:54 - Article Views: 3,885 Benitec Limited (ASX:BLT) (PINK:BNIKF) announced today that Ms Sue MacLeman will step down from the role of Chief Executive Officer (CEO) and Managing Director to pursue other opportunities. She has agreed however to stay actively involved with Benitec as a Strategic Advisor at this exciting time for the Company. A transition arrangement has been put in place. Mr Mel Bridges and Dr John Chiplin will both move to Executive Director roles within the Company and the Board will be further strengthened in the coming months.

	Australian Market Report of March 10: No Exciting News to Lift the Market MAR 10, 2009 13:00 - Article Views: 9,090 Yesterday the Australian market ended slightly higher. The big miners such as BHP Billiton and Rio Tinto pushed the market up despite falls in the banking and finance sector, according to CMC Markets. The benchmark S&P/ASX200 index was up 9 points, or 0.29 per cent, at 3154.5, while the broader All Ordinaries index rose 10 points to 3121.7. Today the big miners are not likely to help the market up after the falls of commodities prices and lacking positive news from the US.

	Australian Market Report of January 29: Market Cheer for "Bad Bank" Idea JAN 29, 2009 13:00 - Article Views: 8,228 Yesterday the Australian shares ended higher led by banking sector. The benchmark S&P/ASX200 share index gained 1.5%, or 51.5 points, to 3495.5 points. The broader All Ordinaries index gained 1.3%, or 42.8 points, to 3435.1.

	Australian Market Report of December 23: Exiting Before Chirstmas DEC 23, 2008 13:00 - Article Views: 6,628 Yesterday, the Australian shares closed lower as investors were leaving the market before Christmas. On Monday, the benchmark S&P/ASX200 index was down 58.3 points, or 1.61%, at 3557.4 points, while the broader All Ordinaries index was 54.9 points, or 1.55% lower, at 3492.3 points. Analysts said the loss was larger than expected, and the negative news from the world markets would impact on the local market.